The inflammatory marker IL-6 was also increased in BC patients (2.650 pg/mL; 1.020-5.910) compared to controls (1.610; 0.8400-3.773) (P=0.0188; Figure 1F) and it correlated with all NETs markers in plasma (Figure 2). The gene discussed is IL6; the disease is breast cancer.